Hepatic Encephalopathy Market Size, Share, Outlook, and Opportunity Analysis, 2018– 2026

1. HEPATIC ENCEPHALOPATHY MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Hepatic Encephalopathy Market - Overview Global Hepatic Encephalopathy Market, by Drug Class (Antibiotics, Laxatives, L-ornithine L- aspartate, and Others), by Route of Administration (Oral, Intravenous, and Rectal), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 355.4 million in 2020 and is estimated to exhibit a CAGR of 5.3% during the forecast period (2020-2027). The increasing prevalence of various risk factors such as hepatitis C, hepatic cirrhosis among the population is expected to drive the global hepatic encephalopathy market growth over the forecast period. For instance, according to the CMAJ Open journal: 2018, prevalence of liver cirrhosis is expected to increase due to the rising cases of hepatitis C and the non-alcoholic fatty liver disease among the Canadian population. Around 30% of people in Canada suffered from liver diseases. Market players are indulged in inorganic activities such as acquisitions, which is expected to expand the product portfolio as well as strengthen the position of the companies in the global market. For instance, in 2018, Ferring Pharmaceuticals Inc. acquired Rebiotix Inc, a clinical stage biotechnology company. This acquisition bought together two innovative healthcare companies that focus on exploring and understanding the human microbiome for developing new solutions for patients. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/hepatic- encephalopathy-market-2596 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Global Hepatic Encephalopathy Market– Impact of Coronavirus (COVID – 19) Pandemic The COVID-19 pandemic is expected to restrain growth of the global hepatic encephalopathy market over the forecast period. According to National center for Biotechnology Information (NCBI), 29th September 2020, the hepatic encephalopathy treatment is required for majority of patients suffering with severe liver damage and the treatment might be delayed due to the pandemic. Although, during the COVID-19 pandemic, the treatment of severe liver damage patients is postponed or even cancelled due to the unavailability of antibiotics, laxatives, and other medications and irregular supply and transportation of drugs. Furthermore, according to the U.S Food and Drug Administration (FDA), 18th September 2020, the COVID-19 pandemic has disrupted the global drug supply due to government-mandated or recommended temporary shutdowns, safety initiatives to ensure employee health and well- being, insufficient labor force, and restrictions on import and export activities, and travel. Antibiotic manufacturing has been particularly affected. Browse 38 Market Data Tables and 27 Figures spread through 149 Pages and in-depth TOC on, Global Hepatic Encephalopathy Market, by Drug Class (Antibiotics, Laxatives, L-ornithine L- aspartate, and Others), by Route of Administration (Oral, Intravenous, and Rectal), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa). Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2596 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Key players are majorly focused on conducting clinical trials for development of new drugs for hepatic encephalopathy, which is expected to drive growth of the global hepatic encephalopathy market over the forecast period. For instance, in 2019, Mallinckrodt Pharmaceuticals conducted clinical trials for MNK-6105 (ornithine phenylacetate) intravenous and MNK-6106 (ornithine phenylacetate) oral medications for preventing the recurrence of chronic hepatic encephalopathy. The trial is currently in phase III of the trials. The increasing distribution of lactulose for treatment of hepatic encephalopathy is expected to drive growth of the global hepatic encephalopathy market over the forecast period. For instance, in April 2017, Cumberland Pharmaceuticals, a U.S.-based specialty pharmaceutical company, and Poly Pharmaceuticals Inc., a privately-held U.S.-based specialty pharmaceutical company signed an agreement for co-promoting the Kristalose (lactulose solution for treatment of hepatic encephalopathy), which is developed by Poly Pharmaceuticals Inc., within the U.S. This multi-year co-promotion partnership will expand current sales for Kristalose across the U.S. Some of the major players operating in the global hepatic encephalopathy market include ASKA Pharmaceutical Co., Ltd., Cosmo Pharmaceuticals N.V., Lupin Limited, Kaleido Biosciences, Kannalife Sciences, Inc., Bausch Health Companies Inc., Ferring Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Umecrine Cognition AB, Norgine B.V., Abbott Laboratories, and QR Science and Technology Development Co. Ltd. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2596 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved